Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
301.33
-6.44 (-2.09%)
At close: May 28, 2025, 4:00 PM
301.33
0.00 (0.00%)
After-hours: May 28, 2025, 4:36 PM EDT
Molina Healthcare Stock Forecast
Stock Price Forecast
According to 15 professional analysts, the 12-month price target for Molina Healthcare stock ranges from a low of $297 to a high of $414. The average analyst price target of $364.8 forecasts a 21.06% increase in the stock price over the next year.
Price Target: $364.80 (+21.06%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 25, 2025.
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 3 | 3 | 3 | 5 | 5 | 5 |
Hold | 7 | 6 | 8 | 7 | 9 | 9 |
Sell | 1 | 1 | 1 | 1 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 12 | 14 | 15 | 16 | 16 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Hold Maintains $339 → $362 | Hold | Maintains | $339 → $362 | +20.13% | Apr 25, 2025 |
Bernstein | Bernstein | Buy Initiates $414 | Buy | Initiates | $414 | +37.39% | Apr 22, 2025 |
Baird | Baird | Buy → Hold Downgrades $331 → $375 | Buy → Hold | Downgrades | $331 → $375 | +24.45% | Apr 15, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $340 → $400 | Strong Buy | Maintains | $340 → $400 | +32.74% | Apr 11, 2025 |
Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Apr 9, 2025 |
Financial Forecast
Revenue This Year
44.65B
from 39.16B
Increased by 14.01%
Revenue Next Year
48.16B
from 44.65B
Increased by 7.87%
EPS This Year
24.73
from 20.42
Increased by 21.09%
EPS Next Year
28.59
from 24.73
Increased by 15.64%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 47.1B | 51.5B | 54.9B | |
Avg | 44.7B | 48.2B | 51.3B | |
Low | 42.7B | 44.9B | 48.0B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 20.2% | 15.3% | 14.0% | |
Avg | 14.0% | 7.9% | 6.6% | |
Low | 9.2% | 0.5% | -0.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 26.00 | 32.55 | 37.38 | |
Avg | 24.73 | 28.59 | 33.08 | |
Low | 23.22 | 27.12 | 30.08 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 27.3% | 31.6% | 30.7% | |
Avg | 21.1% | 15.6% | 15.7% | |
Low | 13.7% | 9.7% | 5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.